Vice President, Medicine Development Leader, Cancer Vaccines, Oncology Research Unit

The Company is seeking a Vice President, Medicine Development Leader to direct the global development of cancer vaccine medicines from late-stage transition through regulatory approval, launch, and lifecycle management. The role sets the asset’s strategic vision and development plan, leads a multidisciplinary team across research, clinical development, manufacturing, regulatory, safety, medical affairs, and commercial functions, and aligns resources and budgets to deliver program objectives. Responsibilities include making evidence-based portfolio decisions, overseeing clinical and regulatory strategies, ensuring data quality and compliance, and incorporating patient perspectives and unmet medical needs into development plans. The leader will also engage senior decision-makers and external stakeholders, support collaborations and business development, and guide patent and lifecycle strategies. Candidates must hold an advanced degree, such as an MD, PhD, PharmD, MBA, or MS, and have global pharmaceutical or biotechnology experience in oncology drug development. Required experience includes leading medicine development and registration, filing BLA, NDA, or MAA submissions, and working across the R&D and commercial lifecycle, including late-stage oncology development, complex clinical trials, regulatory affairs, and manufacturing. Applicants should have a record of leading global, multidisciplinary matrix teams and experience with regulatory requirements, lifecycle planning, and financial and budget management. Expertise in cancer vaccines, therapeutic vaccines, or immuno-oncology combinations is required; familiarity with personalized medicine, novel vaccine platforms, tumor immunology, antigen selection, and biomarker strategies is preferred.